Clinical Trials Browser

Phase 3 × INDUSTRY × bermekimab × Clear all

NCT01767857 2021-06-29

XCITE

Phase 3 Terminated

643 enrolled 16 charts

Gastrointestinal

Colorectal Neoplasms

NCT02138422 2021-03-01

A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms